First Trust Direct Indexing’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-58,781
Closed -$6.68M 574
2024
Q3
$6.68M Sell
58,781
-298
-0.5% -$35.4K 0.36% 43
2024
Q2
$7.31M Buy
59,079
+10,680
+22% +$1.38M 0.45% 31
2024
Q1
$6.39M Buy
48,399
+7,445
+18% +$918K 0.47% 29
2023
Q4
$4.46M Buy
40,954
+6,423
+19% +$667K 0.4% 38
2023
Q3
$3.55M Buy
34,531
+61
+0.2% +$6.58K 0.41% 38
2023
Q2
$3.98M Buy
34,470
+2,419
+8% +$275K 0.44% 33
2023
Q1
$3.41M Buy
32,051
+3,204
+11% +$346K 0.4% 37
2022
Q4
$3.2M Buy
28,847
+918
+3% +$93.8K 0.42% 36
2022
Q3
$2.4M Buy
27,929
+1,145
+4% +$102K 0.35% 46
2022
Q2
$2.44M Buy
26,784
+1,474
+6% +$131K 0.34% 54
2022
Q1
$2.08M Buy
25,310
+5,099
+25% +$402K 0.25% 76
2021
Q4
$1.55M Sell
20,211
-376
-2% -$29.9K 0.2% 108
2021
Q3
$1.55M Buy
20,587
+850
+4% +$64.6K 0.22% 101
2021
Q2
$1.53M Sell
19,737
-873
-4% -$64.9K 0.23% 101
2021
Q1
$1.52M Buy
20,610
+983
+5% +$72.5K 0.4% 47
2020
Q4
$1.53M Buy
+19,627
New +$1.5M 0.41% 39

Other funds holding MRK

First Trust Direct Indexing's MRK Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Merck (MRK) in Q4 2024, closing a stake of 58,781 shares — an estimated $6.68M sold.

First Trust Direct Indexing first reported a position in MRK in Q4 2020 and held it in 16 quarters. The position peaked at $7.31M in Q2 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 58,781 Merck shares in Q4 2024, an estimated $6.68M.
  • First Trust Direct Indexing first reported a position in Merck in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Merck position peaked at $7.31M in Q2 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.